Skip to main content
Top
Published in: Cardiovascular Drugs and Therapy 6/2009

01-12-2009

Resveratrol Supplementation Gender Independently Improves Endothelial Reactivity and Suppresses Superoxide Production in Healthy Rats

Authors: Selen Soylemez, Aylin Sepici, Fatma Akar

Published in: Cardiovascular Drugs and Therapy | Issue 6/2009

Login to get access

Abstract

Purpose

Resveratrol, a polyphenolic compound mainly abundant in red wines, has beneficial cardiovascular effects on various pathological conditions. However, at present, the effect of resveratrol on health promotion remains unclear. Therefore, in this study, we assessed whether long-term resveratrol supplementation changes endothelial function, vascular contractility, nitric oxide and superoxide production in healthy male and female rats.

Methods

Wistar rats were treated with resveratrol (50 mg/l) in their drinking water for 3 weeks. We investigated relaxation to acetylcholine (10−9−10−4 M) and contractions to phenylephrine (10−9−3 × 10−4 M) and angiotensin II (10−10−10−5 M) in either endothelium-intact or denuded aortae from control and resveratrol-treated male and female rats. Aortic superoxide production capacity was measured in response to provocation by angiotensin II and NAD(P)H. Plasma nitrite/nitrate levels and superoxide dismutase (SOD) activity were also evaluated.

Results

Resveratrol supplementation gender independently increased relaxation to acetylcholine and decreased contractions to phenylephrine and angiotensin II in endothelium-intact aortic rings, but not in endothelium-denuded arteries, from healthy male and female rats. This was associated with increased plasma nitrite/nitrate levels. Furthermore, resveratrol caused a refractoriness to angiotensin II and NAD(P)H-induced provocation in superoxide production.

Conclusion

Our results suggest that resveratrol supplementation gender independently could improve the capacity of endothelial function and suppression of oxidative stress under physiological conditions. Resveratrol ingestion indicates a potential for cardiovascular health promotion.
Literature
2.
go back to reference Sato M, Maulik N, Das DK. Cardioprotection with alcohol: role of both alcohol and polyphenolic antioxidants. Ann New York Acad Sci. 2002;957:122–35.CrossRef Sato M, Maulik N, Das DK. Cardioprotection with alcohol: role of both alcohol and polyphenolic antioxidants. Ann New York Acad Sci. 2002;957:122–35.CrossRef
3.
go back to reference Chen CK, Pace-Asciak CR. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol. 1996;27:363–6.PubMed Chen CK, Pace-Asciak CR. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol. 1996;27:363–6.PubMed
4.
go back to reference Orallo F, Alvarez E, Camina M, Leiro JM, Gomez E, Fernandez P. The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol Pharmacol. 2002;61:294–302.CrossRefPubMed Orallo F, Alvarez E, Camina M, Leiro JM, Gomez E, Fernandez P. The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol Pharmacol. 2002;61:294–302.CrossRefPubMed
5.
go back to reference Rakici O, Kiziltepe U, Coskun B, Aslamacı S, Akar F. Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary artery. Int J Cardiol. 2005;105:209–15.CrossRefPubMed Rakici O, Kiziltepe U, Coskun B, Aslamacı S, Akar F. Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary artery. Int J Cardiol. 2005;105:209–15.CrossRefPubMed
6.
go back to reference Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, et al. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation. 2002;106:1652–8.CrossRefPubMed Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, et al. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation. 2002;106:1652–8.CrossRefPubMed
7.
go back to reference Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology. 2000;141:3657–67.CrossRefPubMed Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology. 2000;141:3657–67.CrossRefPubMed
8.
go back to reference Klinge CM, Wickramasinghe NS, Ivanova MM, Dougherty SM. Resveratrol stimulates nitric oxide production by increasing estrogen receptor α-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. FASEB J. 2008;22:2185–97.CrossRefPubMed Klinge CM, Wickramasinghe NS, Ivanova MM, Dougherty SM. Resveratrol stimulates nitric oxide production by increasing estrogen receptor α-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. FASEB J. 2008;22:2185–97.CrossRefPubMed
9.
go back to reference Chow S-E, Hshu Y-C, Wang J-S, Chen J-K. Resveratrol attenuates oxLDL-stimulated NADPH oxidase activity and protects endothelial cells from oxidative functional damages. J Appl Physiol. 2007;102:1520–7.CrossRefPubMed Chow S-E, Hshu Y-C, Wang J-S, Chen J-K. Resveratrol attenuates oxLDL-stimulated NADPH oxidase activity and protects endothelial cells from oxidative functional damages. J Appl Physiol. 2007;102:1520–7.CrossRefPubMed
10.
go back to reference Soylemez S, Gurdal H, Sepici A, Akar F. The effect of long-term resveratrol treatment on relaxation to estrogen in aortae from male and female rats: role of nitric oxide and superoxide. Vasc Pharmacol. 2008;49:97–105.CrossRef Soylemez S, Gurdal H, Sepici A, Akar F. The effect of long-term resveratrol treatment on relaxation to estrogen in aortae from male and female rats: role of nitric oxide and superoxide. Vasc Pharmacol. 2008;49:97–105.CrossRef
11.
go back to reference Zou J-G, Wang Z-R, Huang Y-Z, Cao K-J, Wu JM. Effect of red wine and wine polyphenol resveratrol on endothelial function in hypercholesterolemic rabbits. Int J Mol Med. 2003;11:317–20.PubMed Zou J-G, Wang Z-R, Huang Y-Z, Cao K-J, Wu JM. Effect of red wine and wine polyphenol resveratrol on endothelial function in hypercholesterolemic rabbits. Int J Mol Med. 2003;11:317–20.PubMed
12.
go back to reference Mizutani K, Ikeda K, Kawai Y, Yamori Y. Resveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive rats. J Nutr Sci Vitaminol. 2000;46:78–83.PubMed Mizutani K, Ikeda K, Kawai Y, Yamori Y. Resveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive rats. J Nutr Sci Vitaminol. 2000;46:78–83.PubMed
13.
go back to reference Rush JWE, Quadrilatero J, Levy AS, Ford RJ. Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats. Exp Biol Med. 2007;232:814–22. Rush JWE, Quadrilatero J, Levy AS, Ford RJ. Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats. Exp Biol Med. 2007;232:814–22.
14.
go back to reference Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending lifespan. Cell Metab. 2008;8:157–68.CrossRefPubMed Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending lifespan. Cell Metab. 2008;8:157–68.CrossRefPubMed
15.
go back to reference Kauser K, Rubanyi GM. Gender difference in bioassayable endothelium-derived nitric oxide from isolated rat aortae. Am J Physiol Heart Circ Physiol. 1994;267:H2311–7. Kauser K, Rubanyi GM. Gender difference in bioassayable endothelium-derived nitric oxide from isolated rat aortae. Am J Physiol Heart Circ Physiol. 1994;267:H2311–7.
16.
go back to reference Nickenig G, Baumer AT, Grohe C, Kahlert S, Strehlow K, Rosenkranz S, et al. Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation. 1998;97:2197–201.PubMed Nickenig G, Baumer AT, Grohe C, Kahlert S, Strehlow K, Rosenkranz S, et al. Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation. 1998;97:2197–201.PubMed
17.
go back to reference Crews JK, Murphy JG, Khalil RA. Gender differences in Ca2+ entry mechanisms of vasoconstriction in Wistar-Kyoto and spontaneously hypertensive rats. Hypertension. 1999;34:931–6.PubMed Crews JK, Murphy JG, Khalil RA. Gender differences in Ca2+ entry mechanisms of vasoconstriction in Wistar-Kyoto and spontaneously hypertensive rats. Hypertension. 1999;34:931–6.PubMed
18.
go back to reference Walsh T, Donnelly T, Lyons D. Impaired endothelial nitric oxide bioavailability: a common link between aging, hypertension, and atherogenesis? J Am Geriat Soc. 2009;57:140–5.CrossRefPubMed Walsh T, Donnelly T, Lyons D. Impaired endothelial nitric oxide bioavailability: a common link between aging, hypertension, and atherogenesis? J Am Geriat Soc. 2009;57:140–5.CrossRefPubMed
19.
go back to reference Skatchkov MP, Sperling D, Hink U, Mulsch A, Harrison DG, Sindermann I. Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. Biochem Biophys Res Commun. 1999;254:319–24.CrossRefPubMed Skatchkov MP, Sperling D, Hink U, Mulsch A, Harrison DG, Sindermann I. Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. Biochem Biophys Res Commun. 1999;254:319–24.CrossRefPubMed
20.
go back to reference Coskun B, Soylemez S, Parlar AI, Ulus AT, Katircioglu SF, Akar F. Effect of resveratrol on nitrate tolerance in isolated human internal mammary artery. J Cardiovas Pharmacol. 2006;47:437–45. Coskun B, Soylemez S, Parlar AI, Ulus AT, Katircioglu SF, Akar F. Effect of resveratrol on nitrate tolerance in isolated human internal mammary artery. J Cardiovas Pharmacol. 2006;47:437–45.
21.
go back to reference Chambliss KL, Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endoc Rev. 2002;23:665–86.CrossRef Chambliss KL, Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endoc Rev. 2002;23:665–86.CrossRef
22.
go back to reference Andersen HL, Weis JU, Fjalland B, Korsgaard N. Effect of acute and long-term treatment with 17-β-estradiol on the vasomotor responses in the rat aorta. Br J Pharmacol. 1999;126:159–68.CrossRefPubMed Andersen HL, Weis JU, Fjalland B, Korsgaard N. Effect of acute and long-term treatment with 17-β-estradiol on the vasomotor responses in the rat aorta. Br J Pharmacol. 1999;126:159–68.CrossRefPubMed
23.
go back to reference Gonzales RJ, Walker BR, Kanagy NL. 17β-Estradiol increases nitric oxide-dependent dilation in rat pulmonary arteries and thoracic aorta. Am J Physiol Lung Cell Mol Physiol. 2001;280:L555–64.PubMed Gonzales RJ, Walker BR, Kanagy NL. 17β-Estradiol increases nitric oxide-dependent dilation in rat pulmonary arteries and thoracic aorta. Am J Physiol Lung Cell Mol Physiol. 2001;280:L555–64.PubMed
24.
go back to reference Sobey CG, Weiler JM, Boujaoude M, Woodman OL. Effect of short-term phytoestrogen treatment in male rats on nitric oxide-mediated responses of carotid and cerebral arteries: comparison with 17 β-estradiol. J Pharmacol Exp Therap. 2004;310:135–40.CrossRef Sobey CG, Weiler JM, Boujaoude M, Woodman OL. Effect of short-term phytoestrogen treatment in male rats on nitric oxide-mediated responses of carotid and cerebral arteries: comparison with 17 β-estradiol. J Pharmacol Exp Therap. 2004;310:135–40.CrossRef
25.
go back to reference Gehm BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Nat Acad Sci USA. 1997;94:14138–43.CrossRefPubMed Gehm BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Nat Acad Sci USA. 1997;94:14138–43.CrossRefPubMed
26.
go back to reference Lu R, Serrero G. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J Cell Physiol. 1999;179:297–304.CrossRefPubMed Lu R, Serrero G. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J Cell Physiol. 1999;179:297–304.CrossRefPubMed
27.
go back to reference Miyazaki R, Ichiki T, Hashimoto T, Inanaga K, Imayama I, Sadoshima J, et al. SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells. Arterioscler Throm Vasc Biol. 2008;28:1263–9.CrossRef Miyazaki R, Ichiki T, Hashimoto T, Inanaga K, Imayama I, Sadoshima J, et al. SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells. Arterioscler Throm Vasc Biol. 2008;28:1263–9.CrossRef
28.
go back to reference Aubin M-C, Lajoie C, Clement R, Gosselin H, Calderone A, Perrault LP. Female rats fed a high-fat diet were associated with vascular dysfunction and cardiac fibrosis in the absence of overt obesity and hyperlipidemia: therapeutic potential of resveratrol. J Pharmacol Exp Therap. 2008;325:961–8.CrossRef Aubin M-C, Lajoie C, Clement R, Gosselin H, Calderone A, Perrault LP. Female rats fed a high-fat diet were associated with vascular dysfunction and cardiac fibrosis in the absence of overt obesity and hyperlipidemia: therapeutic potential of resveratrol. J Pharmacol Exp Therap. 2008;325:961–8.CrossRef
29.
go back to reference Bradamante S, Barenghi L, Villa A. Cardiovascular protective effects of resveratrol. Cardiovas Drug Rev. 2004;22:169–88. Bradamante S, Barenghi L, Villa A. Cardiovascular protective effects of resveratrol. Cardiovas Drug Rev. 2004;22:169–88.
30.
go back to reference Mueller CFH, Laude K, McNally JS, Harrison DG. Redox mechanisms in blood vessels. Arterioscler Throm Vasc Biol. 2005;25:274–8.CrossRef Mueller CFH, Laude K, McNally JS, Harrison DG. Redox mechanisms in blood vessels. Arterioscler Throm Vasc Biol. 2005;25:274–8.CrossRef
31.
go back to reference Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R, et al. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res. 2000;86:85–90. Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R, et al. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res. 2000;86:85–90.
32.
go back to reference Didion SP, Faraci FM. Effects of NADH and NADPH on superoxide levels and cerebral vascular tone. Am J Physiol Heart Circ Physiol. 2002;282:H688–95.PubMed Didion SP, Faraci FM. Effects of NADH and NADPH on superoxide levels and cerebral vascular tone. Am J Physiol Heart Circ Physiol. 2002;282:H688–95.PubMed
33.
go back to reference Ungvari Z, Orosz Z, Rivera A, Labinskyy N, Xiangmin Z, Olson S, et al. Resveratrol increases vascular oxidative stress resistance. Am J Physiol Heart Circ Physiol. 2007;292:H2417–24.CrossRefPubMed Ungvari Z, Orosz Z, Rivera A, Labinskyy N, Xiangmin Z, Olson S, et al. Resveratrol increases vascular oxidative stress resistance. Am J Physiol Heart Circ Physiol. 2007;292:H2417–24.CrossRefPubMed
34.
go back to reference Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury, part II: animal and human studies. Circulation. 2003;108:2034–40.CrossRefPubMed Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury, part II: animal and human studies. Circulation. 2003;108:2034–40.CrossRefPubMed
35.
go back to reference Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Disc. 2006;5:493–506.CrossRef Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Disc. 2006;5:493–506.CrossRef
Metadata
Title
Resveratrol Supplementation Gender Independently Improves Endothelial Reactivity and Suppresses Superoxide Production in Healthy Rats
Authors
Selen Soylemez
Aylin Sepici
Fatma Akar
Publication date
01-12-2009
Publisher
Springer US
Published in
Cardiovascular Drugs and Therapy / Issue 6/2009
Print ISSN: 0920-3206
Electronic ISSN: 1573-7241
DOI
https://doi.org/10.1007/s10557-009-6198-z

Other articles of this Issue 6/2009

Cardiovascular Drugs and Therapy 6/2009 Go to the issue